News & Updates

Wearable defibrillators may prevent sudden cardiac death

15 Sep 2021 by

Wearable cardioverter-defibrillators (WCD) help protect newly diagnosed heart failure patients from sudden cardiac death (SCD), according to a recent study.

Wearable defibrillators may prevent sudden cardiac death

15 Sep 2021

COVID-19 mortality high after noninvasive ventilation failure

15 Sep 2021

Patients with the coronavirus disease 2019 (COVID-19) who had failed noninvasive ventilation (NIV) suffer from high rates of in-hospital mortality, a recent study has found.

COVID-19 mortality high after noninvasive ventilation failure

15 Sep 2021

Licogliflozin shows promise in polycystic ovary syndrome

15 Sep 2021

Dual sodium-glucose co-transporter 1/2 (SGLT1/2) inhibition with licogliflozin appears to produce reductions in hyperinsulinaemia and hyperandrogenaemia in women with polycystic ovary syndrome, as shown in a phase II study.

Licogliflozin shows promise in polycystic ovary syndrome

15 Sep 2021

Serious adverse events may compromise functional outcome in stroke patients

15 Sep 2021

About one out of five patients develop severe complications following an acute ischaemic stroke, a study reports. These serious adverse events (SAEs) are more common among older and male patients and are tied to worse functional outcome.

Serious adverse events may compromise functional outcome in stroke patients

15 Sep 2021

Imatinib significantly reduces proinflammatory cytokines in SARS-CoV-2–affected endothelial cells

15 Sep 2021 by

Researchers from The University of Hong Kong (HKU) have uncovered a novel mechanism of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–induced lung injury and vascular damage through epithelial–endothelial cell interaction and demonstrated the immunomodulatory role of imatinib, supporting its use for the treatment of coronavirus-19 (COVID-19).

Imatinib significantly reduces proinflammatory cytokines in SARS-CoV-2–affected endothelial cells

15 Sep 2021

Exercise programme sustains normal heart rate in AF patients

15 Sep 2021 by

Six months of combined supervised exercise training and home-based physical activity helps to prevent atrial fibrillation (AF) recurrence and severity of symptoms in patients with persistent AF, according to the ACTIVE-AF* study presented at ESC 2021.

Exercise programme sustains normal heart rate in AF patients

15 Sep 2021

Air pollution strongly correlated with atherogenesis; intervention study planned

15 Sep 2021 by

A study by the Chinese University of Hong Kong (CUHK) and Chongqing Medical University finds a strong association between air pollution and markers of early atherosclerosis, suggesting a potential target for preventive intervention.

Air pollution strongly correlated with atherogenesis; intervention study planned

15 Sep 2021

Simeprevir potently suppresses SARS-CoV-2 replication, shows synergy with remdesivir

15 Sep 2021 by

An international study led by researchers from The Chinese University of Hong Kong (CUHK) and The University of Hong Kong (HKU) finds that protease inhibitor simeprevir potently reduces severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load and demonstrates synergy with remdesivir in vitro.

Simeprevir potently suppresses SARS-CoV-2 replication, shows synergy with remdesivir

15 Sep 2021

CUHK researchers discover a mutation prognostic of prolonged survival in SCCHN

15 Sep 2021 by

Researchers from the Chinese University of Hong Kong (CUHK) have discovered a novel genetic biomarker associated with extended survival in head and neck squamous cell carcinoma (HNSCC), which is found in almost 20 percent of HNSCC tumours.

CUHK researchers discover a mutation prognostic of prolonged survival in SCCHN

15 Sep 2021

CLAM in R/R AML: High response rates, effective bridge to allo-HSCT

15 Sep 2021 by

One cycle of clofarabine, cytarabine and mitoxantrone (CLAM) achieves an overall response rate (ORR) of >90 percent with a complete remission (CR) rate of nearly 70 percent in a phase II study of Hong Kong patients with refractory/relapsed acute myeloid leukaemia (R/R AML).

CLAM in R/R AML: High response rates, effective bridge to allo-HSCT

15 Sep 2021

News & Updates

Filter by Specialty:

Specialty:

Wearable defibrillators may prevent sudden cardiac death

Wearable defibrillators may prevent sudden cardiac death

COVID-19 mortality high after noninvasive ventilation failure

COVID-19 mortality high after noninvasive ventilation failure

Licogliflozin shows promise in polycystic ovary syndrome

Licogliflozin shows promise in polycystic ovary syndrome

Serious adverse events may compromise functional outcome in stroke patients

Serious adverse events may compromise functional outcome in stroke patients

Imatinib significantly reduces proinflammatory cytokines in SARS-CoV-2–affected endothelial cells

Imatinib significantly reduces proinflammatory cytokines in SARS-CoV-2–affected endothelial cells

Exercise programme sustains normal heart rate in AF patients

Exercise programme sustains normal heart rate in AF patients

Air pollution strongly correlated with atherogenesis; intervention study planned

Air pollution strongly correlated with atherogenesis; intervention study planned

Simeprevir potently suppresses SARS-CoV-2 replication, shows synergy with remdesivir

Simeprevir potently suppresses SARS-CoV-2 replication, shows synergy with remdesivir

CUHK researchers discover a mutation prognostic of prolonged survival in SCCHN

CUHK researchers discover a mutation prognostic of prolonged survival in SCCHN

CLAM in R/R AML: High response rates, effective bridge to allo-HSCT

CLAM in R/R AML: High response rates, effective bridge to allo-HSCT